(Q48008700)

7 February 2018

title

Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-kappa B. (English)

1 reference

7 February 2018

0 references

8

Elias Toubi

1 reference

7 February 2018

Aharon Kessel

1

1 reference

7 February 2018

Itzhak Rosner

2

1 reference

7 February 2018

Michael Rozenbaum

3

1 reference

7 February 2018

Devy Zisman

4

1 reference

7 February 2018

Anca Sagiv

5

1 reference

7 February 2018

Zehava Shmuel

6

1 reference

7 February 2018

Edmond Sabo

7

1 reference

7 February 2018

publication date

1 January 2004

1 reference

7 February 2018

Journal of Clinical Immunology

published in

1 reference

7 February 2018

volume

24

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

30-36

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1023/b:joci.0000018060.36183.bb

exact match

0 references

cites work

Apoptosis in the rheumatic diseases

1 reference

12 December 2020

Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis

1 reference

12 December 2020

Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy

1 reference

12 December 2020

Immune aberrations in B and T lymphocytes derived from chronic urticaria patients.

1 reference

12 December 2020

Cytokine production and serum levels in systemic sclerosis

1 reference

12 December 2020

Suppressor cell function and t lymphocyte subpopulations in peripheral blood of patients with progressive systemic sclerosis

1 reference

12 December 2020

Immunopathogenesis of systemic sclerosis

1 reference

12 December 2020

Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

1 reference

12 December 2020

Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity

1 reference

12 December 2020

T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis)

1 reference

12 December 2020

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

12 December 2020

Immune modulation during treatment of systemic sclerosis with plasmapheresis and immunosuppressive drugs

1 reference

12 December 2020

Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression

1 reference

12 December 2020

Regulation of apoptosis in the immune system

1 reference

12 December 2020

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival

1 reference

12 December 2020

Role of T cells and cytokines in effecting fibrosis.

1 reference

12 December 2020

Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons

1 reference

12 December 2020

Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations

1 reference

12 December 2020

Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis

1 reference

12 December 2020

Derangement of apoptosis-related lymphocyte homeostasis in systemic sclerosis

1 reference

12 December 2020

Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies

1 reference

12 December 2020

The pathogenesis of scleroderma (systemic sclerosis, SSc).

1 reference

12 December 2020

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

12 December 2020

Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis

1 reference

12 December 2020

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

12 December 2020

The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis

1 reference

12 December 2020

Soluble and cellular markers of immune activation in patients with systemic sclerosis

1 reference

12 December 2020

Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

12 December 2020

10.1023/B:JOCI.0000018060.36183.BB

Identifiers

DOI

1 reference

7 February 2018

Dimensions Publication ID

1024212881

0 references

1 reference

7 February 2018